公开(公告)号：US11911453B2

公开(公告)日：2024-02-27

申请号：US16965589

申请日：2019-01-28

Applicant: ModernaTX, Inc.

Inventor： Giuseppe Ciaramella ,  Kapil Bahl ,  Amy Espeseth ,  Andrew J. Bett ,  Pedro Cejas ,  Lan Zhang ,  Christine Shaw

IPC: A61K39/12 ,  A61K9/00 ,  A61K39/00

CPC classification number: A61K39/12 ,  A61K9/0019 ,  A61K2039/53 ,  A61K2039/55555

Abstract: The disclosure relates to respiratory syncytial virus (RSV) ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines. The vaccine can be formulated in a lipid nanoparticle.

公开(公告)号：US20240299525A1

公开(公告)日：2024-09-12

申请号：US18418127

申请日：2024-01-19

Applicant: ModernaTX, Inc.

Inventor： Giuseppe Ciaramella ,  Kapil Bahl ,  Amy Espeseth ,  Andrew J. Bett ,  Pedro Cejas ,  Lan Zhang ,  Christine Shaw

IPC: A61K39/12 ,  A61K9/00 ,  A61K39/00

CPC classification number: A61K39/12 ,  A61K9/0019 ,  A61K2039/53 ,  A61K2039/55555

Abstract: The disclosure relates to respiratory syncytial virus (RSV) ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines. The vaccine can be formulated in a lipid nanoparticle.

公开(公告)号：US20210046173A1

公开(公告)日：2021-02-18

申请号：US16965589

申请日：2019-01-28

Applicant: ModernaTX, Inc.

Inventor： Giuseppe Ciaramella ,  Kapil Bahl ,  Amy Espeseth ,  Andrew J. Bett ,  Pedro Cejas ,  Lan Zhang ,  Christine Shaw

IPC: A61K39/12

Abstract: The disclosure relates to respiratory syncytial virus (RSV) ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines. The vaccine can be formulated in a lipid nanoparticle.